KNSA Hedge Fund Ownership (Q2 2026)

Kiniksa Pharmaceuticals Intl (KNSA)

265 + Investors. Track Smart Money conviction in KNSA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — KNSA

Based on 268 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 6 quarters in a row

last 6Q

For 6 consecutive quarters, more hedge funds added KNSA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

268 hedge funds hold KNSA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +44% more funds vs a year ago

fund count last 6Q

+82 new funds entered over the past year (+44% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟡

Slight buying edge — 58% buying

161 buying117 selling

Last quarter: 161 funds bought or added vs 117 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

📈

More new buyers each quarter (+30 vs last Q)

new funds entering per quarter

Funds opening a new KNSA position: 46 → 42 → 43 → 73. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔄

Mostly new holders — 36% entered in last year

■ 24% conviction (2yr+) ■ 40% medium ■ 36% new

Only 65 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Value +39% but shares only +7% — price-driven

Value

+38%

+7%

Last quarter: the total dollar value of institutional holdings rose +39%, but actual share count only changed +7%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

📈

Growing discovery — still being found

47 → 46 → 42 → 43 → 73 new funds/Q

New funds entering each quarter: 46 → 42 → 43 → 73. A growing number of institutions are discovering KNSA each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

📊

Mixed cohorts — 4% veterans, 47% new entrants

■ 4% veterans ■ 49% 1-2yr ■ 47% new

Of 274 current holders: 11 (4%) held 2+ years, 134 held 1–2 years, 129 (47%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

🏆

Elite ownership — 46% AUM from top-100 funds

46% from top-100 AUM funds

52 of 267 holders are among the 100 largest funds by AUM, controlling 46% of total institutional value in KNSA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

4.3

out of 10

Moderate Exit Risk

Exit risk score 4.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	265	229	15.72%
13F Shares	47M	47M	1.37%
Total Value	$2.93B	$2.14B	36.84%
New Positions	72	43	+29
Increased Positions	85	74	+11
Closed Positions	35	36	-1
Reduced Positions	82	87	-5
Total Calls	3	4	-25.0%
Total Puts	4	3	33.33%
PUT/CALL Ratio	1.33	0.75	Bearish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

265

229

15.72%

13F Shares

47M

1.37%

Total Value

$2.93B

$2.14B

36.84%

New Positions

+29

Increased Positions

+11

Closed Positions

-1

Reduced Positions

-5

Total Calls

-25.0%

Total Puts

33.33%

PUT/CALL Ratio

1.33

0.75

Bearish

Institutional Holders (2026 Q2)

265 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in KNSA. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 KNSA holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Spruce Street Capital LP	11.52%	918,070	$58.7M
2	Tang Capital Management LLC	6.56%	2,259,889	$144.5M
3	Rubric Capital Management LP	2.35%	3,999,800	$255.8M
4	Stempoint Capital LP	2.30%	209,234	$13.4M
5	Essex Investment Management Co LLC	2.02%	241,382	$15.4M
6	Rice Hall James & Associates, LLC	1.95%	624,928	$40.0M
7	Penn Capital Management Company, LLC	1.49%	368,114	$23.6M
8	Lisanti Capital Growth, LLC	1.23%	87,305	$5.6M
9	Baker BROS. Advisors LP	0.91%	2,834,643	$181.3M
10	Globeflex Capital L P	0.76%	93,396	$6.0M
11	Superstring Capital Management LP	0.76%	18,867	$1.2M
12	ArrowMark Colorado Holdings LLC	0.57%	215,546	$13.8M
13	Oberweis Asset Management Inc/	0.55%	413,034	$26.4M
14	Mark Sheptoff Financial Planning, LLC	0.54%	16,000	$1.0M
15	Soleus Capital Management, L.P.	0.54%	246,353	$15.8M
16	Orbimed Advisors LLC	0.50%	420,600	$26.9M
17	Legato Capital Management LLC	0.46%	87,297	$5.6M
18	Braidwell LP	0.43%	183,822	$11.8M
19	Precision Wealth Strategies, LLC	0.43%	22,348	$1.4M
20	Granahan Investment Management, LLC	0.35%	151,725	$9.7M
21	Artia Global Partners LP	0.34%	29,200	$1.9M
22	Peregrine Capital Management LLC	0.34%	161,464	$10.3M
23	Virtus Investment Advisers, LLC	0.33%	22,411	$1.4M
24	Informed Momentum Co LLC	0.32%	55,765	$3.6M
25	Castleark Management LLC	0.30%	174,032	$11.1M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Kiniksa Pharmaceuticals Intl (KNSA)

What does the Smart Money Trend signal show for KNSA?

Buying streak — 6 quarters in a row: For 6 consecutive quarters, more hedge funds added KNSA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for KNSA?

Slight buying edge — 58% buying: Last quarter: 161 funds bought or added vs 117 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for KNSA holders?

Elite ownership — 46% AUM from top-100 funds: 52 of 267 holders are among the 100 largest funds by AUM, controlling 46% of total institutional value in KNSA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held KNSA?

Mostly new holders — 36% entered in last year: Only 65 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Kiniksa Pharmaceuticals Intl (KNSA)

Smart Money Signals — KNSA

Buying streak — 6 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +44% more funds vs a year ago

Slight buying edge — 58% buying

More new buyers each quarter (+30 vs last Q)

Mostly new holders — 36% entered in last year

Value +39% but shares only +7% — price-driven

Growing discovery — still being found

Mixed cohorts — 4% veterans, 47% new entrants

Elite ownership — 46% AUM from top-100 funds

Institutional Sentiment Summary — KNSA

Hedge Fund Ownership: KNSA

Market Analysis: KNSA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: KNSA

Hedge Fund Positioning: KNSA

Statistics: KNSA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Kiniksa Pharmaceuticals Intl (KNSA)

Welcome to 13Foresight!